Gilde Healthcare buys Acti-Med

The GP said in a statement that it intends to support the company in the development of its product portfolio, as well as with increasing its manufacturing and design capacity.

Rafael Natanek, a partner at Gilde Healthcare's private equity team, told Unquote how the deal came about. "We have been actively landscaping the medtech and instruments sectors in Europe, and specifically the German-speaking countries, as these sub-sectors are traditionally well represented in the DACH area. Historically, Gilde Healthcare has invested successfully in a wide range of medtech, healthtech and instruments companies, so we were able to act fast when Acti-Med came to market. The transaction was executed relatively swiftly, as we can draw upon the local network and expertise of our German office in Frankfurt."

Natanek said that Acti-Med is the fourth investment from Gilde Healthcare Services III, following Eetgemak, Ace Pharmaceuticals and Tandarts Today. The vehicle held a final close in March 2019 on €200m, and targets lower-mid-market healthcare providers and medical product suppliers with EBITDA of €2-15m and revenues of €10-30m, according to Unquote Data. The fund deploys equity tickets of €10-40m.

Gilde's healthcare strategy also has a venture and growth capital arm. The GP held a final close for its latest fund in the strategy, Gilde Healthcare V, in March 2020 on its hard-cap of $450m. The fund makes investments of $10-40m per deal, targeting both US and European opportunities.

Company
Founded in 1997 and headquartered in Freiensteinau, Acti-Med produces medical and pharmaceutical equipment, specialising in cannula systems. Its product portfolio is divided between ready-for-market and ready-for-cleanroom products. The company has additional operations in Kozerkí in Poland and employs 200 staff.

People
Gilde Healthcare – Rafael Natanek (partner).
Acti-Med – Andreas Schwalb (founder, CEO).

Advisers
Equity – Greenberg Traurig (legal); LEK (commercial due diligence); Ebner Stolz (financial due diligence).
Vendor – DZ Bank Corporate Finance (M&A).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Buyouts
• DACH
• Healthcare
• Germany
• Gilde Equity Management Benelux